Stock Events

Stock Events

Celldex Therapeutics (TCE2.STU) Q1 2026 Earnings

25FebConfirmed

Q1 2026

-1.03

-0.98

-0.92

-0.87

Details

Expected EPS

-0.8652368930800001

Actual EPS

-1.0326568

Surprise EPS

-0.17

Surprise Percent

+19.35%

Description

Celldex Therapeutics (TCE2.STU) has reported earnings of -1.0326568 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.